Andere talen Zeria Pharmaceutical Co., Ltd.

Aandelen

4559

JP3428850006

Beurs gesloten - Japan Exchange Andere beurzen 08:00:00 22-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1.959 ^JPY	-1,06%		-4,21%	-2,88%

09/05	Zeria Pharmaceutical Co. Geeft geconsolideerde winstverwachting voor de eerste zes maanden en het volledige jaar eindigend op 31 maart 2025	CI
23/04	Borsch Med Pte. Ltd. Introduceert Chondroïtine Supplementen van Zeria Pharmaceutical Co. Ltd in Singapore voor gezonde gewrichten	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Zeria Pharmaceutical Co., Ltd. Announces Year End Dividend for the Full Year Ending March 31, 2024, Payable on June 28, 2024	09/05
Zeria Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the First Six Months and Full Year Ending March 31, 2025	09/05
Zeria Pharmaceutical Co., Ltd. Provides Second Quarter and Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2025	09/05
Borsch Med Pte. Ltd. Introduces Chondroitin Supplements of Zeria Pharmaceutical Co. Ltd to Singapore for Healthy Joints	23/04
Zeria Pharmaceutical's Profit Up 41% in Fiscal Q1-Q3	16/02
Japanese Shares End Firmer on Friday on BoJ Policy Outlook	17/11
Zeria Pharmaceutical Books Higher Fiscal H1 Attributable Profit on Loss Provision Reversal	17/11
Zeria Pharmaceutical Co., Ltd. Announces Dividend for the Second Quarter of Fiscal Year Ending March 31, 2024, Payable on December 1, 2023	16/11
Zeria Pharmaceutical Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2024	16/11
Zeria Pharmaceutical’s Attributable Profit Up 12.1% in Fiscal Q1 on Absence of Forex Losses	23-08-23
Zeria Pharmaceutical Co., Ltd. Provides Dividend Forecast for the Fiscal Year Ending March 31, 2024	22-08-23
Zeria Pharmaceutical Co., Ltd. Provides Consolidated Financial Forecast for the Six Months of 2024 and the Fiscal Year Ending March 31, 2024	22-08-23
Zeria Pharmaceutical Co., Ltd. Provides Dividend Forecast for the Second Quarter of 2024	22-08-23
Zeria Pharmaceutical : 69th Business Report (From April 1, 2022 to March 31, 2023.)	25-07-23
Zeria Pharmaceutical : Notice of the 69th Ordinary Stockholders' General Assembly	26-05-23
Tranche Update on Zeria Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2022.	16-05-23
Zeria Pharmaceutical Co., Ltd.'s Equity Buyback announced on May 11, 2022, has closed with 263,900 shares, representing 0.6% for ¥545.29 million.	12-05-23
Zeria Pharmaceutical Co., Ltd. Provides Year End Dividend Guidance for the Full Year Ending March 31, 2024	11-05-23
Zeria Pharmaceutical Co., Ltd. Announces Year End Dividend for the Full Year Ending March 31, 2023, Payable on June 30, 2023; Provides Second Quarter Dividend Guidance for the Full Year Ending March 31, 2024	11-05-23
Zeria Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the First Six Months and Full Year Ending March 31, 2024	11-05-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Zeria Pharmaceutical Co., Ltd.

Aandelen

4559

JP3428850006

Andere talen

Filters